C4 Therapeutics, Inc.

Q2 2024 13F Holders

Symbol
CCCC
CUSIP
12529R107
Type
Equity
Class
COM STK
Num filers
116
Total reported value, excl. options
$281M
Manager Report Date Value ($000) Shares Option Type